Repeatability and Response Study of Absorptive Clearance Scans

NCT01887197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

OTHER: Absorptive clearance scan
DRUG: inhaled hypertonic saline (7%)
DRUG: mannitol inhalation powder

Sponsor

Tim Corcoran